National Taiwan University Hospital
Taipei, Taiwan
NCT Number: NCT04319055
Computer vision using deep learning architecture is broadly used in auto-recognition. In the research, the deep learning model which is trained by categorized single-eye images is applied to achieve the good performance of the model in blepharoptosis auto-diagnosis.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Observational
Taipei, Taiwan
This auto-diagnosis system of blepharoptosis using machine learning architecture will assist in telemedicine, such as early screening of childhood ptosis for prompt referral and treatment. People could use this software via mobile devices to get a primitive diagnosis before they reach the physicians. Furthermore, in primary health care, where there is no oculoplastic surgeon, the software could assist primary care physicians or general ophthalmologists, in identifying the need for a referral.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
[Inclusion Criteria]
[Exclusion Criteria]
Time frame: Through study completion, an average of 1 year
An Artificial Intelligence Approach
Time frame: Through study completion, an average of 1 year
An Artificial Intelligence Approach
Time frame: Through study completion, an average of 1 year
An Artificial Intelligence Approach
Time frame: Through study completion, an average of 1 year
The model interpretability is accessed by Grad-CAM (Class Activation Maps).
National Taiwan University Hospital
Other
Artificial Intelligence-Assisted Facial, Periocular, and Orbital Analysis and Surgical Planning
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06226545
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Beverly Hills, California, United States
View Trial DetailsNCT03753893
Amaurosis Fugax, Arterial Occlusive Diseases
View Trial DetailsNCT06112340
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Miami, Florida, United States
View Trial DetailsNCT05276063
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Beverly Hills, California, United States
View Trial Details